SCHEMBL18459205

SCHEMBL18459205

Cc1ncc(Cc2ccccn2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.53
HRH3 Q9Y5N1 2/20 0.47
HRH4 Q9H3N8 1/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
TAAR1 Q96RJ0 1/20 0.46
ALOX15 P16050 1/20 0.46
CYP1A2 P05177 3/20 0.43
CYP2D6 P10635 1/20 0.43
HRH1 P35367 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LIN28A Q9H9Z2 1/20 0.41
CYP2C19 P33261 1/20 0.41
TSHR P16473 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18459202 0.81 L3MBTL1 (0.54) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL19591008 0.81 L3MBTL1 (0.53) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL25172245 0.81 L3MBTL1 (0.53) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL8736874 0.78 L3MBTL1 (0.65) L3MBTL1HRH3ALDH1A1LMNATAAR1
SCHEMBL29373231 0.77 L3MBTL1 (0.68) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL64435 0.77 L3MBTL1 (0.68) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL41191 0.76 L3MBTL1 (0.59) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL29830938 0.76 L3MBTL1 (0.59) L3MBTL1HRH3HRH4ALDH1A1LMNA
Bromide SCHEMBL10759788 0.75 L3MBTL1 (0.66) L3MBTL1HRH3HRH4ALDH1A1LMNA
SCHEMBL18459204 0.75 CALM1 (0.55) HRH3LMNATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10818851-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-10-27 US disclosed
EP-3188732-B1 TETRAHYDROISOQUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF DIACYLGLYCERIDE O-ACYLTRANSFERASE 2 MERCK SHARP & DOHME (US) 2019-07-24 EP disclosed
US-9899611-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-02-20 US disclosed
US-9780313-B2 Carbazole-based compound and organic light-emitting device including the same SASMSUNG DISPLAY CO., LTD. (KR) 2017-10-03 US disclosed
US-20170033297-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170033297-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CCNE2, CCNE1, CCNA1 L3MBTL1 250/4885HRH3 2861/4885HRH4 2711/4885
US-10818851-B2 Condensed cyclic compound and organic light-emitting device including the same CCNE2, CCNE1, CCNA1 L3MBTL1 250/4885HRH3 2861/4885HRH4 2711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.